These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21357694)

  • 1. Novel role of base excision repair in mediating cisplatin cytotoxicity.
    Kothandapani A; Dangeti VS; Brown AR; Banze LA; Wang XH; Sobol RW; Patrick SM
    J Biol Chem; 2011 Apr; 286(16):14564-74. PubMed ID: 21357694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential role of base excision repair proteins in mediating cisplatin cytotoxicity.
    Sawant A; Floyd AM; Dangeti M; Lei W; Sobol RW; Patrick SM
    DNA Repair (Amst); 2017 Mar; 51():46-59. PubMed ID: 28110804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity.
    Kothandapani A; Sawant A; Dangeti VS; Sobol RW; Patrick SM
    Nucleic Acids Res; 2013 Aug; 41(15):7332-43. PubMed ID: 23761438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis.
    Enoiu M; Jiricny J; Schärer OD
    Nucleic Acids Res; 2012 Oct; 40(18):8953-64. PubMed ID: 22810206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin.
    De Silva IU; McHugh PJ; Clingen PH; Hartley JA
    Nucleic Acids Res; 2002 Sep; 30(17):3848-56. PubMed ID: 12202770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.
    Arora S; Kothandapani A; Tillison K; Kalman-Maltese V; Patrick SM
    DNA Repair (Amst); 2010 Jul; 9(7):745-53. PubMed ID: 20418188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.
    Sawant A; Kothandapani A; Zhitkovich A; Sobol RW; Patrick SM
    DNA Repair (Amst); 2015 Nov; 35():126-36. PubMed ID: 26519826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair.
    Bulgar AD; Weeks LD; Miao Y; Yang S; Xu Y; Guo C; Markowitz S; Oleinick N; Gerson SL; Liu L
    Cell Death Dis; 2012 Jan; 3(1):e252. PubMed ID: 22237209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway.
    Zhang N; Liu X; Li L; Legerski R
    DNA Repair (Amst); 2007 Nov; 6(11):1670-8. PubMed ID: 17669695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.
    Usanova S; Piée-Staffa A; Sied U; Thomale J; Schneider A; Kaina B; Köberle B
    Mol Cancer; 2010 Sep; 9():248. PubMed ID: 20846399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Base excision repair enzymes protect abasic sites in duplex DNA from interstrand cross-links.
    Admiraal SJ; O'Brien PJ
    Biochemistry; 2015 Mar; 54(9):1849-57. PubMed ID: 25679877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells.
    Arora S; Heyza J; Zhang H; Kalman-Maltese V; Tillison K; Floyd AM; Chalfin EM; Bepler G; Patrick SM
    Oncotarget; 2016 Nov; 7(46):75104-75117. PubMed ID: 27650543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.
    Spanswick VJ; Lowe HL; Newton C; Bingham JP; Bagnobianchi A; Kiakos K; Craddock C; Ledermann JA; Hochhauser D; Hartley JA
    BMC Cancer; 2012 Sep; 12():436. PubMed ID: 23020514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.
    Pérez C; Leng M; Malinge JM
    Nucleic Acids Res; 1997 Feb; 25(4):896-903. PubMed ID: 9016644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA repair enzyme MUTYH potentiates cytotoxicity of the alkylating agent MNNG by interacting with abasic sites.
    Raetz AG; Banda DM; Ma X; Xu G; Rajavel AN; McKibbin PL; Lebrilla CB; David SS
    J Biol Chem; 2020 Mar; 295(11):3692-3707. PubMed ID: 32001618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer.
    Conner KL; Shaik AN; Ekinci E; Kim S; Ruterbusch JJ; Cote ML; Patrick SM
    DNA Repair (Amst); 2020 Mar; 87():102802. PubMed ID: 31981740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines.
    Moufarij MA; Phillips DR; Cullinane C
    Mol Pharmacol; 2003 Apr; 63(4):862-9. PubMed ID: 12644587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3 enzymes mediate efficacy of cisplatin and are epistatic with base excision repair and mismatch repair in platinum response.
    Conner KL; Shaik AN; Marshall KA; Floyd AM; Ekinci E; Lindquist J; Sawant A; Lei W; Adolph MB; Chelico L; Siriwardena SU; Bhagwat A; Kim S; Cote ML; Patrick SM
    NAR Cancer; 2020 Dec; 2(4):zcaa033. PubMed ID: 33196045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
    Zhu G; Myint M; Ang WH; Song L; Lippard SJ
    Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.
    Clingen PH; Arlett CF; Hartley JA; Parris CN
    Exp Cell Res; 2007 Feb; 313(4):753-60. PubMed ID: 17188678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.